MedWorm: Bisoprolol

BISOPROLOL FUMARATEtablet, Film Coated [Mylan Pharmaceuticals Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Mon, 08 Mar 2010 05:00:00 +0100

Updated Date: Mar 8, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

BISOPROLOL FUMARATEtablet, Film Coated [Aurobindo Pharma Limited]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 08 Jan 2010 05:00:00 +0100

Updated Date: Jan 8, 2010 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Cilazapril increases plasma ghrelin concentration in obese patients with arterial hypertension.

Endokrynologia Polska — Fri, 01 Jan 2010 00:00:00 +0100

Conclusions: 1. Our data do not support the major role of ghrelin in blood pressure regulation in obesity. 2. An increase of plasma ghrelin concentration after treatment with cilazapril was observed. (Pol J Endocrinol 2010; 61 (1): 21-27). PMID: 20205100 [PubMed - in process] (Source: Endokrynologia Polska)

Low-dose peri-operative beta-blockade does not seem to increase stroke risk

NeLM - News — Thu, 10 Dec 2009 00:00:00 +0100

Source: Am J Cardiology Area: News A retrospective analysis of three trials studying beta-blockade to prevent cardiovascular events in at-risk patients undergoing non-cardiac surgery suggests that the regimen studied did not significantly increase stroke risk. Peri-operative beta-blockade has been widely used in patients at risk of cardiovascular events who are undergoing non-cardiac surgery, as evidence suggests that it reduces the risk of serious cardiac events. A large controlled trial, however (the POISE trial; Lancet 2008; 371: 1839-47), found that the regimen used in that study, metoprolol m/r 200mg daily, was associated with an increased risk of stroke. This cast doubt on the safety of such treatment. An earlier, smaller study (DECREASE-I) had previously shown benefit fr...

New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery

Journal of Vascular Surgery — Thu, 03 Dec 2009 00:00:00 +0100

Conclusion: Routine stress testing should not be performed before VS. The Lee index should be used to stratify risk in patients undergoing VS. Patients with ≥3 risk factors or active cardiac conditions should undergo stress testing, if VS can be delayed. All VS patients, except those with 0 risk factors, should be considered for a β-blocker (bisoprolol, 2.5-5 mg/d started 1 month before VS, titrated to a pulse (Source: Journal of Vascular Surgery)

Atrial tachycardia with 1:1 atrioventricular conduction precipitated by propafenone

Emergency Medicine Journal — Tue, 24 Nov 2009 18:04:19 +0100

A 58-year-old man presented to the emergency department with sudden onset rapid palpitations and significant presyncope while walking on the flat. The previous day he had undergone DC cardioversion for atrial fibrillation (AF) which had been initially successful. However, 6 h after cardioversion he was aware of intermittently raised but regular heart rates. On arrival at the emergency department (ED) he was well with no haemodynamic compromise. The ECG showed an atrial tachycardia instead of AF. Medications consisted of propafenone 300 mg twice daily, bisoprolol 5 mg at night and warfain. Bisoprolol was increased to 5 mg twice daily and he was discharged with a plan for outpatient ablation. He collapsed in the hospital car park with rapid palpations, chest tightness and vagal symptoms. On ...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

BISOPROLOL FUMARATEtablet, Film Coated [Physicians Total Care, Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Mon, 23 Nov 2009 05:00:00 +0100

Updated Date: Nov 23, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

ZEBETA (Bisoprolol Fumarate) Tablet [Duramed Pharmaceuticals, Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Thu, 19 Nov 2009 05:00:00 +0100

Updated Date: Nov 19, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Impact of Prophylactic β-Blocker Therapy to Prevent Stroke After Noncardiac Surgery

The American Journal of Cardiology — Mon, 16 Nov 2009 00:00:00 +0100

In conclusion, with a low-dose bisoprolol regimen started ≥30 days before surgery, no association was observed between β-blocker use and postoperative stroke. (Source: The American Journal of Cardiology)

Differential Effects of Oral {beta} Blockade on Cardiovascular and Sympathetic Regulation

Journal of Cardiovascular Pharmacology and Therapeutics — Wed, 11 Nov 2009 02:11:41 +0100

In patients with hypertension, β blockade decreases muscle sympathetic nerve activity (MSNA; micrographic technique) expressed in burst frequency (burst/min) but does not affect MSNA expressed in burst incidence (burst/100 heart beats), because reductions in blood pressure (BP) upon each diastole continue to deactivate the arterial baroreceptors, but at a slower heart rate (HR). We studied the effects of oral β blockade on MSNA and baroreflex sensitivity (BRS) in normal participants. Bisoprolol (5 mg, 1 week) was administered in 10 healthy young adults, using a double-blind, placebo-controlled, randomized cross-over study design. The beat-to-beat mean RR interval (RR) and systolic blood pressure (SBP) series were analyzed by power spectral analysis and power computation over the ...

Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure

NeLM - Disease Focused Reviews — Fri, 06 Nov 2009 00:00:00 +0100

Source: DARE Area: Evidence > Disease Focused Reviews CRD Summary: This review concluded that the magnitude of heart rate reduction was statistically significantly associated with the survival benefit of beta-blockers in heart failure, but the dose of beta-blocker was not. The majority of the review process and the synthesis were well conducted. Despite the absence of a validity assessment, the conclusions appear likely to be reliable. [Included studies assessed metoprolol, carvedilol, bisoprolol, bucindolol, nebivolol and atenolol. ] CRD Commentary: The review question was clear and was supported by specific inclusion criteria. The authors searched several relevant databases and included attempts to locate unpublished studies in their strategy. This, together with the lack of languag...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Differential effects of β-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise

British Journal of Clinical Pharmacology — Thu, 05 Nov 2009 00:00:00 +0100

CONCLUSIONS Despite reducing brachial blood pressure, acute [beta]-adrenoreceptor blockade in man at rest and during exercise does not reduce central blood pressure. (Source: British Journal of Clinical Pharmacology)

Low-dose Fixed Combination of Bisoprolol/Hydrochlorothiazide as First Line for Hypertension: A Review of the Rationale and Clinical Evidence

Angiology — Thu, 22 Oct 2009 08:29:10 +0100

Essential hypertension is a heterogeneous multifactorial disease. Data from the National Health and Nutritional Examination Survey and from the World Health Organization have clearly demonstrated that, worldwide, less than 30% of hypertensive patients are adequately controlled by our currently accepted blood pressure goals. Although monotherapy is often unable to achieve blood pressure goals, the use of fixed low-dose combination drugs as alternative treatment seems to be related to a better antihypertensive efficacy and higher response rates in the low range of doses as the result of complementary mechanisms of antihypertensive effects. Indeed clinical trials have shown that initial low-dose combination therapy is superior as compared with treatment by the stepped-care and the sequential ...

Bisoprolol: First report of a fixed drug eruption: case report

Reactions — Mon, 19 Oct 2009 13:04:56 +0100

(Source: Reactions)

Liquid chromatography tandem mass spectrometry method for determination of bisoprolol in human plasma using d5-bisoprolol as the internal standard.

Biomedical Chromatography : BMC — Sun, 04 Oct 2009 23:00:00 +0100

Authors: Liu GY, Wang W, Jia JY, Lu C, Liu YM, Zhang MQ, Liu Y, Li SJ, Yu C A simple, reliable and sensitive liquid chromatography tandem mass spectrometry (LC-MS/MS) protocol was developed and validated for quantification of bisoprolol in human plasma. The sample was pretreated with a simple procedure of protein precipitation and an isotope-labeled d5-bisoprolol was used as internal standard. The chromatographic separation was performed on a Capcell Pak C(18) MG III column (100 mm x 2.0 mm, 5 microm). The protonated ion of the analyte was detected in positive ionization by multiple reaction monitoring mode. The mass transition pairs of m/z 326.3 --> 116.3 and m/z 331.3 --> 121.3 were used to detect bisoprolol and the internal standard, respectively. Linearity, accuracy, precisio...

Respiratory Effects of β-blocker Therapy in Heart Failure

Cardiovascular Drugs and Therapy — Tue, 29 Sep 2009 16:56:52 +0100

In conclusion, it is possible to use β-blockers in HF patients even in the presence of lung function impairment, but their use should be guided by a combination of lung function evaluation and knowledge of the pharmacological properties of each molecule Content Type Journal ArticleDOI 10.1007/s10557-009-6195-2Authors Piergiuseppe Agostoni, Università di Milano Centro Cardiologico Monzino-IRCCS, Istituto di Cardiologia via Parea 4 20138 Milan ItalyPietro Palermo, Università di Milano Centro Cardiologico Monzino-IRCCS, Istituto di Cardiologia via Parea 4 20138 Milan ItalyMauro Contini, Università di Milano Centro Cardiologico Monzino-IRCCS, Istituto di Cardiologia via Parea 4 20138 Milan Italy Journal Cardiovascular Drugs and TherapyOnline ISSN 1573-7241Print ISSN 0920-3206...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

BISOPROLOL FUMARATE TABLETS (Bisoprolol Fumarate) Tablet [Unichem Pharmaceuticals (USA), Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Tue, 22 Sep 2009 05:00:00 +0100

Updated Date: Sep 22, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

ZIAC (Bisoprolol Fumarate And Hydrochlorothiazide) Tablet, Film Coated [Duramed Pharmaceuticals Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 11 Sep 2009 05:00:00 +0100

Updated Date: Sep 11, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Interaction of beta-blockers with the renal uptake transporter OCT2

Diabetes, Obesity and Metabolism — Wed, 09 Sep 2009 23:00:00 +0100

Conclusion: These in vitro results demonstrate that alterations of uptake transporter function by beta-blockers have to be considered as potential mechanisms underlying drug[ndash]drug interactions in the kidney. (Source: Diabetes, Obesity and Metabolism)

bisoprolol, Zebeta

MedicineNet Heart General — Wed, 02 Sep 2009 07:00:00 +0100

Title: bisoprolol, ZebetaCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 9/2/2009 (Source: MedicineNet Heart General)

bisoprolol, Zebeta

MedicineNet High Blood Pressure General — Wed, 02 Sep 2009 07:00:00 +0100

Title: bisoprolol, ZebetaCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 9/2/2009 (Source: MedicineNet High Blood Pressure General)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

bisoprolol, Zebeta

MedicineNet Medications General — Wed, 02 Sep 2009 07:00:00 +0100

Title: bisoprolol, ZebetaCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 9/2/2009 (Source: MedicineNet Medications General)

bisoprolol, Zebeta

MedicineNet Senior Health General — Wed, 02 Sep 2009 07:00:00 +0100

Title: bisoprolol, ZebetaCategory: MedicationsCreated: 3/26/1998 2:30:00 PMLast Editorial Review: 9/2/2009 (Source: MedicineNet Senior Health General)

The effectiveness of collaborative medicine reviews in delaying time to next hospitalization for patients with heart failure in the practice setting: results of a cohort study.

Australian Family Physician — Tue, 01 Sep 2009 00:00:00 +0100

CONCLUSIONS: Medicines review in the practice setting is effective in delaying time to next hospitalization for heart failure in those treated with heart failure medicines. PMID: 19808372 [PubMed - indexed for MEDLINE] (Source: Australian Family Physician)

Survival among patients with left ventricular systolic dysfunction treated with atenolol.

Congestive Heart Failure — Mon, 31 Aug 2009 23:00:00 +0100

Authors: Kapoor JR, Heidenreich PA Metoprolol succinate, carvedilol, and bisoprolol are approved for use in heart failure. Other beta-blockers have been found to be inferior (metoprolol tartrate) or have not been studied (atenolol). The authors compared all-cause mortality following treatment with either atenolol, carvedilol, or metoprolol tartrate for 974 patients with left ventricular function < or =40%. The unadjusted mortality at 6 months was lower with atenolol (3.2%) and carvedilol (4.2%) when compared with metoprolol tartrate (7.5%, P< or =.039). However, patients with atenolol were older but had less prior heart failure. After adjustment for the propensity to be treated with atenolol, patients actually treated with atenolol had a significantly lower risk of death compared...

The effect of an evening dose of a long-acting beta-blocker on the autonomic tone in patients with congestive heart failure.

Kardiologia Polska — Mon, 31 Aug 2009 23:00:00 +0100

Conclusion: An evening dose of a beta-blocker is more effective than a morning dose in reversing adverse changes in the autonomic nervous system activity in CHF patients. PMID: 19838952 [PubMed - as supplied by publisher] (Source: Kardiologia Polska)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol: Exacerbation of psoriasis: case report

Reactions — Mon, 24 Aug 2009 12:02:41 +0100

(Source: Reactions)

Unichem gets FDA nod to market hypertension drug

The Economic Times Healthcare and Biotech News — Thu, 20 Aug 2009 14:18:35 +0100

Unichem Laboratories Ltd said it has received the US Food and Drug Administration approval to sell its anti hypertension drug, bisoprolol fumarate, tablets in 5mg and 10 mg doses. (Source: The Economic Times Healthcare and Biotech News)

A New Liquid Chromatography-Tandem Mass Spectrometry Method for Determination of Bisoprolol in Human Plasma Samples

Journal of Biomedicine and Biotechnology — Wed, 19 Aug 2009 11:38:14 +0100

Liquid chromatography (LC) coupled with mass spectrometry (MS) detection is one of the most powerful analytical tools for organic compound analysis. The advantages of using LC/MS methods over HPLC methods include: selectivity, chromatographic integrity, peak assignment, structural information, and rapid method development. In this paper, a new liquid chromatography-tandem mass spectrometry (LC-MS/MS) method has been developed and validated for the determination of bisoprolol in human plasma samples, using metoprolol as internal standard and liquid-liquid extraction procedure. The assay has proven to be sensitive, specific and reproducible, suitable to determine the bisoprolol concentration, following a single oral administration of a 10 mg bisoprolol tablet in 22 healthy volunteers,...

Changes in components of left ventricular mechanics under selective beta-1 blockade: insight from traditional and new technologies in echocardiography

European Journal of Echocardiography — Mon, 10 Aug 2009 23:00:00 +0100

Conclusion In hypertensive subjects with preserved LV EF, parameters of longitudinal LV systolic mechanics may not reflect the LV myocardial contractility status in steady-state conditions under short-term treatment with β1-block. (Source: European Journal of Echocardiography)

One-Year Renal and Cardiac Effects of Bisoprolol versus Losartan in Recently Diagnosed Hypertensive Patients: A Randomized, Double-Blind Study

Clinical Drug Investigation — Mon, 10 Aug 2009 10:20:09 +0100

(Source: Clinical Drug Investigation)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol/doxazosin/valsartan: Sarcoidosis to anhydrous colloidal silica excipient: case report

Reactions — Sun, 26 Jul 2009 10:51:00 +0100

(Source: Reactions)

Clinical trials update from the European Society of Cardiology heart failure meeting 2009: CHANCE, B-Convinced, CHAT, CIBIS-ELD, and Signal-HF

European Journal of Heart Failure — Thu, 23 Jul 2009 23:00:00 +0100

This paper provides information and a commentary on trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the annual meeting of the Heart Failure Association of the European Society of Cardiology held in Nice. The CHANCE study showed a substantial reduction in morbidity and mortality in a randomized controlled trial (RCT) of a multidisciplinary management programme for patients with chronic heart failure in Russia. Data from the B-Convinced study, also an RCT, suggest that continuation of beta-blocker (BB) therapy in patients hospitalized with worsening heart failure may be associated with improved outcomes when compared with treatment discontinuation. The CHAT study suggests that telephone support can improve prognosis in heart failure patients li...

Effects of AT1 receptor and beta1 receptor blocking on blood pressure, peripheral hemodynamic and lipid profile in statin-treated hypertensive hypercholesterolemic patients

Fundamental and Clinical Pharmacology — Wed, 24 Jun 2009 23:00:00 +0100

Recent evidences suggest a relationship between angiotensin 1 (AT1) receptor gene expression and low density lipoprotein cholesterol (LDL-C) plasma level. We enrolled 16 untreated hypertensive hypercholesterolemic patients (57.4 ± 7 years old) in a randomized, single-blind, cross-over design. All the patients were allocated to treatment with simvastatin 20 mg/day for 2 weeks, then randomly assigned to telmisartan (40[ndash]80 mg/day) or bisoprolol (5[ndash]10 mg/day). After 4 weeks the antihypertensive drugs have been withdrawn for a wash-out period of 2 weeks when they were treated with simvastatin alone, then they have been allocated to the alternative antihypertensive treatment for four additional weeks. We measured: systolic (SBP) and diastolic BP (DBP), 24-h mean BP (MBP), Baseline a...

Bisoprolol in patients with heart failure and moderate to severe chronic obstructive pulmonary disease: a randomized controlled trial

European Journal of Heart Failure — Tue, 23 Jun 2009 23:00:00 +0100

Conclusion Initiation of bisoprolol in patients with HF and concomitant moderate or severe COPD resulted in a reduction in FEV1. However, symptoms and quality of life were not impaired. (Source: European Journal of Heart Failure)

Use of a Nurse-led Intervention to Optimize Beta-blockade for Reducing Cardiac Events After Major Noncardiac Surgery

Medscape Critical Care Headlines — Mon, 08 Jun 2009 21:00:56 +0100

Does using an algorithm-based strategy for bisoprolol titration reduce cardiac events after major non-cardiac surgery? American Heart Journal (Source: Medscape Critical Care Headlines)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Reversed-phase high-performance liquid chromatographic enantioresolution of six beta-blockers using dinitrophenyl-l-Pro-N-hydroxysuccinimide ester, N-succinimidyl-(S)-2-(6-methoxynaphth-2-yl) propionate and twelve variants of Sanger's reagent as chiral derivatizing reagents.

Biomedical Chromatography : BMC — Sun, 31 May 2009 23:00:00 +0100

Authors: Bhushan R, Tanwar S Twelve chiral derivatizing reagents (CDRs) were synthesized by substituting one of the fluorine atoms in 1,5-difluoro-2,4-dinitrobenzene (DFDNB) with three optically pure amines [(R)-(-)-1-cyclohexylethylamine, (+)-dehydroabietylamine and (S)-(-)-alpha,4-dimethylbenzylamine], six amino acid amides [l-Ala-NH(2), l-Phe-NH(2), l-Val-NH(2), l-Leu-NH(2), l-Met-NH(2) and d-Phg-NH(2)] and three amino acids [l-Ala, l-Val and l-Leu]. In addition, dinitrophenyl-l-Pro-N-hydroxysuccinimide ester and N-succinimidyl-(S)-2-(6-methoxynaphth-2-yl) propionate were also synthesized and used as CDR. Keeping in view the presence of an amino group, diastereomers of six beta-blockers (atenolol, propranolol, bisoprolol, metoprolol, salbutamol, and carvedilol) were synthesized by r...

Effects of Telmisartan and Bisoprolol on Blood Pressure, Peripheral Haemodynamic and Lipid Profile in Statin-Treated Hypertensive Hypercholesterolaemic Patients

High Blood Pressure — Mon, 25 May 2009 02:30:57 +0100

(Source: High Blood Pressure)

Effects of Telmisartan and Bisoprolol on Blood Pressure, Peripheral Haemodynamic and Lipid Profile in Statin-Treated Hypertensive Hypercholesterolaemic Patients.

High Blood Pressure & Cardiovascular Prevention — Sat, 23 May 2009 02:55:59 +0100

Page: 7DOI: 10.2165/00151642-200916010-00002Authors: Veronesi, Maddalena; Cicero, Arrigo F.G.; Prandin, Maria Grazia; Di Gregori, Valentina; Ambrosioni, Ettore; Borghi, Claudio (Source: High Blood Pressure & Cardiovascular Prevention)

Use of a nurse-led intervention to optimize beta-blockade for reducing cardiac events after major noncardiac surgery.

American Heart Journal — Wed, 01 Apr 2009 04:00:00 +0100

CONCLUSIONS: These data confirm a persistent CE rate after major noncardiac surgery despite nurse-led dose titration of bisoprolol. Cardiac events were equivalent to a UC strategy based on DbE results. PMID: 19332211 [PubMed - in process] (Source: American Heart Journal)

Bisoprolol and carvedilol in healthy dogs

Advances in Small Animal Medicine and Surgery — Wed, 01 Apr 2009 04:00:00 +0100

Chronic β1-adrenoceptor signaling occurs in a failing heart. The use of β-adrenoceptor blockers is beneficial in management of humans with heart failure. Second- and third-generation β-adrenoceptor blockers effects include improved systolic function, prevention of worsening systolic function, and reduced remodeling. Both β1-adrenoceptor-selective agents and third-generation pan-adrenoceptor blocking compounds are effective in prolonging survival in humans with chronic heart failure. There has been increased interest in the use of β-adrenoceptor blockers in management strategies for heart failure associated with myxomatous valve degeneration in dogs. (Source: Advances in Small Animal Medicine and Surgery)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Skeletal muscle proteins oxidation in chronic right heart failure in rats: Can different beta-blockers prevent it to the same degree?

International Journal of Cardiology — Sat, 14 Mar 2009 04:00:00 +0100

CONCLUSIONS: Nebivolol seems better than bisoprolol in CHF by decreasing apoptosis and cytokines induced muscle wastage, preventing fibers shift and protein oxidation. Nebivolol by stimulating NO generation may have prevented protein oxidation. It could be speculated that ROS release, pro-inflammatory cytokines production and NF-kappa-B activation may play a key role. These positive changes could produce a favorable impact on exercise capacity in man. PMID: 19289250 [PubMed - as supplied by publisher] (Source: International Journal of Cardiology)

Nebivolol: a third-generation beta-blocker for hypertension.

Clinical Therapeutics — Sun, 01 Mar 2009 00:00:00 +0100

CONCLUSIONS: Nebivolol is a cardioselective beta-blocker that has been reported to be efficacious and well tolerated for achieving BP control in patients with hypertension. Preliminary evidence suggests a potential for reduced mortality in patients with heart failure. PMID: 19393838 [PubMed - indexed for MEDLINE] (Source: Clinical Therapeutics)

Chiral separation of beta-adrenergic blockers on CelluCoat column by HPLC.

Talanta — Wed, 11 Feb 2009 19:27:16 +0100

Authors: Ali I, Gaitonde VD, Aboul-Enein HY, Hussain A The chiral separation of 10 beta-adrenergic blockers (acebutalol, alprenolol, bufuralol, bisoprolol, celiprolol, carazolol, indenolol, metoprolol, oxprenolol and propranolol) was achieved on CelluCoat column (250mmx4.6mm, 5mum particle size). The mobile phases used were (90:10:0.2, v/v/v) and (95:5:0.2, v/v/v) combinations of n-heptane-ethanol-diethylamine, respectively. The flow rates were 0.5, 1.0 and 2.0mLmin(-1) with detection at 225nm. The capacity (k), selectivity (alpha) and resolution (R(s)) factors were 0.44-12.91, 1.12-2.19 and 1.00-9.50, respectively. The proposed supra-molecular models indicated that the chiral resolution were governed by pi-pi interactions, hydrogen bondings and steric effect. PMID: 19203609 [PubMe...

Chiral separations of some beta-adrenergic agonists and antagonists on AmyCoat column by HPLC.

Chirality — Tue, 10 Feb 2009 05:00:00 +0100

Authors: Ali I, Saleem K, Gaitonde VD, Aboul-Enein HY, Hussain I Sixteen beta-adrenergic antagonists namely acebutalol, alprenolol, atenolol, bisoprolol, bopindolol, bufurolol, carazolol, celiprolol, indenolol, metaprolol, nebivolol, oxprenolol, practolol, propranolol, tertalol, and timolol, and two beta-adrenergic agonists namely cimeterol and clenbuterol were resolved on AmyCoat (150 x 46 mm, 3 mum size of silica particle) by using (85:15:0.1, v/v/v), (90:10:0.1, v/v/v), and (95:05:0.1, v/v/v) combinations of n-heptane, ethanol, and diethylamine solvents, respectively. The flow rates used were 0.5, 1.0, 2.0, and 3.0 ml/min with detection at 225 nm. The values of capacity, separation, and resolution factors ranged from 0.38 to 19.70, 1.08-2.33, and 1.0 and 4.50, respectively. The maxi...

Bisoprolol in patients with chronic heart failure undergoing noncardiac surgery

Future Medicine: Aging Health — Thu, 05 Feb 2009 09:52:18 +0100

Aging Health , February 2009, Vol. 5, No. 1, Pages 19-27. (Source: Future Medicine: Aging Health)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol/propofol interaction: Bradycardia: case report

Reactions — Sun, 01 Feb 2009 06:07:02 +0100

(Source: Reactions)

Bisoprolol/propofol interaction: Bradycardia: case report.

Reactions Weekly — Sat, 31 Jan 2009 06:58:40 +0100

Page: 6 (Source: Reactions Weekly)

Hemodynamic evaluation of bisoprolol after coronary artery surgery in patients with altered left ventricular function

Cardiovascular Drugs and Therapy — Sat, 31 Jan 2009 06:56:00 +0100

Summary Bisoprolol is a new cardioselective beta1 adrenergic blocking agent without intrinsic sympathomimetic activity but with minimal effects on myocardial contractility. Bisoprolol was compared to propranolol in 24 patients after cardiac surgery for coronary artery bypass graft (CABG). Each patient had been treated preoperatively with beta-blocking agents and had a cineangiographic left ventricular ejection fraction between 35% and 55%. Patients were randomized to receive orally either 10 mg of propranolol three times a day or 5 mg of bisoprolol once a day. Both drugs resulted in a significant and similar decrease in heart rate. This was associated with significant decreases in cardiac index, stroke index, and thermodilution right ventricular ejection fraction 6 hours af...

Resident physician and hospital pharmacist familiarity with patient discharge medication costs

Pharmacy World & Science — Thu, 29 Jan 2009 11:10:13 +0100

Conclusion Resident physicians and hospital pharmacists are unfamiliar with what patients must pay for drug therapy once discharged. Content Type Journal ArticleCategory Research ArticleDOI 10.1007/s11096-009-9280-5Authors Kerry Wilbur, Qatar University College of Pharmacy PO Box 2713 Doha Qatar Journal Pharmacy World & ScienceOnline ISSN 1573-739XPrint ISSN 0928-1231 (Source: Pharmacy World & Science)

Full recovery of Takotsubo cardiomyopathy (apical ballooning) in two days.

International Journal of Cardiology — Mon, 19 Jan 2009 05:00:00 +0100

Authors: Eitel I, Lücke C, Behrendt F, Sareban M, Gutberlet M, Schuler G, Thiele H Takotsubo cardiomyopathy (TTC) is a new clinical entity characterised by acute but rapidly reversible left ventricular systolic dysfunction. This case report demonstrates the unique finding of a complete normalization of left ventricular function in a patient with TTC in only 36 h documented by cardiac magnetic resonance imaging. To our best knowledge, this is the most rapid complete recovery of left ventricular apical ballooning reported, yet. Medical management of our patient included optimized antihypertensive therapy with intravenous administration of the alpha-1-adrenergic blocker urapidil and the ss-blocker bisoprolol in highest recommended doses. Although optimal management of TTC has not bee...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Development and validation of a simultaneous HPLC method for estimation of bisoprolol fumarate and amlodipine besylate from tablets

Indian Journal of Pharmaceutical Sciences — Sat, 20 Dec 2008 09:28:00 +0100

Vora D N, Kadav A AIndian Journal of Pharmaceutical Sciences 2008 70(4):542-546A fast, robust and stability indicating RP-HPLC method was developed for simultaneous determination of bisoprolol fumarate and amlodipine besylate in tablets. The mobile phase was mixture of 25 mM ammonium acetate adjusted to pH 5.0 and methanol (65: 35) at 0.8 ml/min. The stationary phase was Luna C18-2 column (3 m, 50x4.6 mm ID). UV detection was performed at 230 nm. Retention time was 1.45 min and 3.91 min for bisoprolol and amlodipine, respectively. Linearity was established in the range of 8-33 µg/ml. Mean recovery was 99.1% and 98.6% for bisoprolol fumarate and amlodipine besylate, respectively. (Source: Indian Journal of Pharmaceutical Sciences)

ORIGINAL INVESTIGATION: Comparative Effectiveness of {beta}-Blockers in Elderly Patients With Heart Failure

Archives of Internal Medicine — Mon, 08 Dec 2008 05:00:00 +0100

Conclusion In this elderly population, the comparative effectiveness of EBBBs vs non-EBBBs was similar for 1-year survival, whereas the rehospitalization rate was higher for patients receiving EBBBs. (Source: Archives of Internal Medicine)

Renin-Angiotensin System and alpha-Adducin Gene Polymorphisms and Their Relation to Responses to Antihypertensive Drugs: Results From the GENRES Study.

American Journal of Hypertension — Thu, 04 Dec 2008 05:00:00 +0100

ConclusionsCommon polymorphisms of ADD1, AGT, ACE, and AGTR1 do not markedly predict BP responses to amlodipine, bisoprolol, HCT, and losartan, at least in white hypertensive men.American Journal of Hypertension 2008; doi:10.1038/ajh.2008.343American Journal of Hypertension 2008; doi:10.1038/ajh.2008.343. PMID: 19057513 [PubMed - as supplied by publisher] (Source: American Journal of Hypertension)

Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure.

NDT Plus — Mon, 01 Dec 2008 05:00:00 +0100

This report describes this complication. The patient presented with high-grade fever, haemolytic anaemia and haemophagocytic-syndrome-related pancytopaenia. Toxoplasma gondii diagnosis was ascertained by blood and bone-marrow PCR assays. After 6 weeks with Clindamycin plus pyrimethamine therapies and despite negativation of T. gondii blood PCR assay, the patient developed left-ventricular failure. After adding sulfamethoxazole/ trimethoprim, ramipril, digoxine, bisoprolol and spironolactone, he progressively recovered. Anti-T. gondii therapy was continued for 6 months. Four years later he received a third kidney allograft: at that time anti-T. gondii antibodies had become negative. The outcome was uneventful despite immunosuppression but with inclusion of sulfamethoxazole/trimethoprim prop...

Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.

American Journal of Veterinary Research — Mon, 01 Dec 2008 05:00:00 +0100

Conclusions and Clinical Relevance-After oral administration, carvedilol underwent extensive first-pass metabolism and had limited bioavailability; bisoprolol had less first-pass effect and higher bioavailability. Collectively, these differences suggested that, in dogs, bisoprolol has less interindividual pharmacokinetic variability, compared with carvedilol. PMID: 19046015 [PubMed - in process] (Source: American Journal of Veterinary Research)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Trends and inequities in beta-blocker prescribing for heart failure.

The British Journal of General Practice — Mon, 01 Dec 2008 05:00:00 +0100

CONCLUSION: Recommended beta-blocker use has risen in the UK but remains low and inequitable, with many patients still treated with beta-blockers that are not recommended in guidelines. This suggests further improvements in prescribing are still possible. PMID: 19068160 [PubMed - in process] (Source: The British Journal of General Practice)

Bisoprolol

Practical Diabetes International — Fri, 17 Oct 2008 04:00:00 +0100

No Abstract. (Source: Practical Diabetes International)

Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: A prospective randomized trial

International Journal of Cardiology — Sun, 10 Aug 2008 23:00:00 +0100

Conclusions: Postoperative oral bisoprolol and amiodarone are equally effective for prophylaxis of AF after CABG. Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases. Both regimens were well tolerated. (Source: International Journal of Cardiology)

Postoperative oral amiodarone versus oral bisoprolol as prophylaxis against atrial fibrillation after coronary artery bypass graft surgery: A prospective randomized trial.

International Journal of Cardiology — Sat, 09 Aug 2008 04:00:00 +0100

CONCLUSIONS: Postoperative oral bisoprolol and amiodarone are equally effective for prophylaxis of AF after CABG. Treatment with bisoprolol resulted in a trend to lower ventricular response rate in AF cases. Both regimens were well tolerated. PMID: 18694603 [PubMed - as supplied by publisher] (Source: International Journal of Cardiology)

The Comparative Effects of Long-Term Carvedilol versus Bisoprolol Therapy on QT Dispersion in Patients with Chronic Heart Failure

Cardiology — Thu, 24 Jul 2008 08:30:33 +0100

Cardiology 2009;112:168-173 (DOI:10.1159/000147950) (Source: Cardiology)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Depression worsens outcomes in elderly patients with heart failure: An analysis of 48,117 patients in a community setting.

European Journal of Heart Failure — Tue, 17 Jun 2008 04:00:00 +0100

CONCLUSION: Among elderly patients with HF, depression was independently associated with poor clinical outcomes mostly due to an increase in vascular events. PMID: 18565789 [PubMed - as supplied by publisher] (Source: European Journal of Heart Failure)

Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial

Clinical Research in Cardiology — Tue, 10 Jun 2008 05:59:18 +0100

Abstract Background Chronic heart failure (CHF) is a widespread disease with severe quality of life impairment and a poor prognosis. Beta-blockers are the mainstay of CHF therapy; yet they are under-prescribed and under-dosed in clinical practice. This is particularly evident in elderly patients, which may be due to a fear of side-effects or intolerance. Beta-blockers have further not been adequately tested in patients with diastolic CHF, which is particularly common in elderly patients. Finally, comparative data on the use of different beta-blockers in patients with CHF is scarce. Aim To compare the tolerance of bisoprolol and carvedilol in elderly patients with CHF. Methods CIBIS-ELD is an investigator-initiated, multi-centre, 1:1 rando...

Clinical Effects of Initial 6 Months Monotherapy with Bisoprolol versus Enalapril in the Treatment of Patients with Mild to Moderate Chronic Heart Failure. Data from the CIBIS III Trial

Cardiovascular Drugs and Therapy — Thu, 05 Jun 2008 09:59:20 +0100

Conclusions Bisoprolol and enalapril had a similar effect on the combined end-point of mortality or hospitalization during 6 months monotherapy. However, more worsening HF events were observed in the bisoprolol group. Content Type Journal ArticleDOI 10.1007/s10557-008-6116-9Authors Daniela Dobre, University Medical Centre Groningen, University of Groningen Department of Clinical Pharmacology Antonius Deusinglaan 1 9713 AV Groningen The NetherlandsDirk J. van Veldhuisen, University Medical Centre Groningen, University of Groningen Department of Cardiology, Thoraxcenter Groningen The NetherlandsMichael A. Goulder, Nottingham Clinical Research Limited Nottingham UKHenry Krum, Monash University/Alfred Hospital Department of Clinical Pharmacology and Therapeutics Melbo...

Identification and guided treatment of ventricular dysfunction in general practice using blood B-type natriuretic peptide.

The British Journal of General Practice — Sun, 01 Jun 2008 04:00:00 +0100

CONCLUSION: About 10% of patients with diabetes or cardiovascular disease on GP morbidity registers have a persistently raised plasma BNP concentration. Simple adjustment of their drug treatment may reduce their BNP and associated mortality risk, but further up-titration against BNP is only possible if the within-person biological variability of measurement can be reduced. PMID: 18505615 [PubMed - in process] (Source: The British Journal of General Practice)

[Prescribing beta blockers in elderly patients with heart failure]

Presse Medicale — Thu, 29 May 2008 16:43:54 +0100

The objective is to reach the target dose (10mg/d for bisoprolol and nebivolol), given the dose-response effect that exists for beta blockers in elderly people with heart failure. In the case of low blood pressure, antihypertensive treatments must be reduced or stopped (for example, nitrate derivatives or calcium channel blockers). A reduction in the dosage of any diuretic dosage and finally of the beta blocker may follow, if necessary. Should bradycardia occur, any anti-bradycardia treatments (such as digoxin or amiodarone) must be reduced or stopped before the beta blocker dosage is reduced. PMID: 18450415 [PubMed - in process] (Source: Presse Medicale)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Therapeutics and Clinical Risk Management — Wed, 21 May 2008 15:09:38 +0100

This article will summarize evidence for the efficacy of bisoprolol in the treatment of HF.Keywords: bisoprolol, heart failure, beta-blockers (Source: Therapeutics and Clinical Risk Management)

Bisoprolol in the treatment of chronic heart failure

Vascular Health and Risk Management — Wed, 21 May 2008 14:48:45 +0100

Pascal de Groote1, Pierre-Vladimir Ennezat2, Fréderic Mouquet11Service de Cardiologie C, 2Service des soins intensifs cardiologiques, Hôpital Cardiologique, Centre Hospitalier Régional et Universitaire de Lille, FranceAbstract: Bisoprolol fumarate is a highly selective beta-1 receptor blocker. Bisoprolol has been extensively studied in three large mortality trials in stable chronic heart failure (CHF) patients. The CIBIS trial enrolled 641 patients and demonstrated the good tolerability of bisoprolol in a large CHF population, without evidence for any harmful effect. The CIBIS-II study was the first large randomized, double-blind, placebo-controlled study demonstrating in 2647 patients a dramatic reduction in mortality with a beta-blocking agent in CHF patients. CIBIS-I...

Effects of extended-release metoprolol in patients undergoing non-cardiac surgery (POISE trial)

NeLM news - Cardiology — Tue, 13 May 2008 00:00:00 +0100

Results from the PeriOperative ISchemic Evaluation (POISE) trial, published early online in the Lancet, suggest that the use of perioperative beta-blockers in patients undergoing non-cardiac surgery prevents non-fatal myocardial infarction but increases the risk of non-fatal stroke. The authors recommend that more large trials in this area are needed urgently, and that current guidelines recommending beta-blockers for patients undergoing non-cardiac surgery should reconsider their recommendations in light of these findings. The authors note that research so far in this area has shown mixed results; small trials have suggested that beta-blockers may reduce the occurrence of major cardiac events (MACE) in patients undergoing non-cardiac surgery; whereas larger trials have shown no benefit. ...

Laboratory tests as predictors of the antihypertensive effects of amlodipine, bisoprolol, hydrochlorothiazide and losartan in men: results from the randomized, double-blind, crossover GENRES Study.

Journal of Hypertension — Mon, 12 May 2008 23:43:34 +0100

Page: 1250DOI: 10.1097/HJH.0b013e3282fcc37fAuthors: Suonsyrja, Timo; Hannila-Handelberg, Tuula; Paavonen, Kristian J; Miettinen, Helena E; Donner, Kati; Strandberg, Timo; Tikkanen, Ilkka; Tilvis, Reijo; Pentikainen, Pertti J; Kontula, Kimmo; Hiltunen, Timo P (Source: Journal of Hypertension)

Bisoprolol Fumarate And Hydrochlorothiazide(Bisoprolol Fumarate And Hydrochlorothiazide) Tablet, Coated [Sandoz Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Mon, 05 May 2008 05:00:00 +0100

Updated Date: May 5, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

[Prescribing beta blockers in elderly patients with heart failure.]

Presse Medicale — Tue, 29 Apr 2008 04:00:00 +0100

β-Blocker pharmacogenetics in heart failure

Heart Failure Reviews — Fri, 25 Apr 2008 10:18:00 +0100

Abstract β-Blockers (metoprolol, bisoprolol, and carvedilol) are a cornerstone of heart failure (HF) treatment. However, it is well recognized that responses to a β-blocker are variable among patients with HF. Numerous studies now suggest that genetic polymorphisms may contribute to variability in responses to a β-blocker, including left ventricular ejection fraction improvement, survival, and hospitalization due to HF exacerbation. This review summarizes the pharmacogenetic data for β-blockers in patients with HF and discusses the potential implications of β-blocker pharmacogenetics for HF patients. Content Type Journal ArticleDOI 10.1007/s10741-008-9094-xAuthors Jaekyu Shin, University of Florida Department of Pharmacy Practice, College of Pharmacy, Center for Ph...

Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats.

European Journal of Heart Failure — Mon, 07 Apr 2008 04:00:00 +0100

CONCLUSION: beta-blocker administration, particularly at high dose, improved the survival rate of the DHF model, at least partly through the attenuation of inflammatory changes and oxidative stress. PMID: 18400557 [PubMed - as supplied by publisher] (Source: European Journal of Heart Failure)

Pediatric Heart Failure Therapy with beta-Adrenoceptor Antagonists.

Paediatric Drugs — Wed, 19 Mar 2008 21:37:45 +0100

This article reviews these topics using experience as well as data from all the recent pediatric studies on the use of beta-blockers to treat congestive heart failure, especially when related to systolic ventricular dysfunction. PMID: 18345722 [PubMed - as supplied by publisher] (Source: Paediatric Drugs)

Bisoprolol Fumarate(Bisoprolol Fumarate) Tablet, Coated [Sandoz Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Wed, 19 Mar 2008 05:00:00 +0100

Updated Date: Mar 19, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol Fumarate(Bisoprolol Fumarate) Tablet, Film Coated [Aurobindo Pharma Limited]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 25 Jan 2008 05:00:00 +0100

Updated Date: Jan 25, 2008 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Bisoprolol for congestive heart failure

Expert Opinion: Expert Opinion on Pharmacotherapy: Table of Contents — Fri, 18 Jan 2008 06:14:46 +0100

Expert Opinion on Pharmacotherapy , February 2008, Vol. 9, No. 2, Pages 293-300. Background: β-Blockers are a cornerstone in the treatment of systolic heart failure treatment, but not all β-blockers are effective or in this setting. Objective: To define the role of bisoprolol, a highly selective β1-antagonist in congestive heart ... (Source: Expert Opinion: Expert Opinion on Pharmacotherapy: Table of Contents)

Bisoprolol Fumarate And Hydrochlorothiazide(Bisoprolol Fumarate And Hydrochlorothiazide) Tablet, Film Coated [Mylan Pharmaceuticals Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 21 Dec 2007 05:00:00 +0100

Updated Date: Dec 21, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Which beta blocker has the best evidence for use in heart failure?

NLH Question Answering Service — Fri, 30 Nov 2007 14:41:24 +0100

The 2007 SIGN guideline on chronic heart failure discusses the use of beta-blockers and recommends:"Bisoprolol, carvedilol or nebivolol should be the beta blocker of first choice for the treatment of patients with chronic heart failure due to left ventricular systolic dysfunction. " [1]A second British guideline, one by CKS (formerly PRODIGY) makes similar recommendations:"Which beta-blocker should I use? Bisoprolol and carvedilol are both licensed and recommended for the treatment of heart failure. (Source: NLH Question Answering Service)

Ziac(Bisoprolol Fumarate And Hydrochlorothiazide) Tablet, Film Coated [DURAMED PHARMACEUTICALS, INC.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 09 Nov 2007 05:00:00 +0100

Updated Date: Nov 9, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Medium-term effects of bisoprolol administration on renal hemodynamics and function in mild to moderate essential hypertension.

Advances in Therapy — Thu, 01 Nov 2007 04:00:00 +0100

This study was designed to evaluate the antihypertensive efficacy and effects on renal hemodynamics and function of bisoprolol during medium-term (6 mo) treatment of patients with mild to moderate essential hypertension. After a 2-wk run-in period on placebo, 87 consecutive hypertensive patients (46 men, 41 women) according to ESH-ESC (European Society of Hypertension/European Society of Cardiology) guidelines, aged from 27 to 64 y (mean age, 50+/-11 y), without renal or cardiovascular disease, were enrolled and assigned to treatment with bisoprolol 5 mg once daily for 6 mo. At recruitment and at 6 mo after treatment, renal function was assessed and renal hemodynamics evaluated in all patients through radioisotope studies. The mediumterm effects of bisoprolol included a significant reducti...

Zebeta(Bisoprolol Fumarate) Tablet [DURAMED PHARMACEUTICALS, INC.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 19 Oct 2007 05:00:00 +0100

Updated Date: Oct 19, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

Comparison of the beneficial effect of beta-blockers on mortality in patients with ischaemic or non-ischaemic systolic heart failure: A meta-analysis of randomised controlled trials.

European Journal of Heart Failure — Wed, 10 Oct 2007 04:00:00 +0100

CONCLUSION: The magnitude of the prognostic benefit conferred by beta-blockers for overall mortality in non-ischaemic HF appears to be very similar to that in ischaemic HF. PMID: 17936068 [PubMed - as supplied by publisher] (Source: European Journal of Heart Failure)

Comparative Dose Titration Responses to the Introduction of Bisoprolol or Carvedilol in Stable Chronic Systolic Heart Failure

Cardiovascular Drugs and Therapy — Wed, 26 Sep 2007 17:42:32 +0100

Conclusions In this study we found similar degrees and rate of onset of HR, HRV and BP response to both carvedilol and bisoprolol in treated LVSD patients. Carvedilol appears to show superior HRV rises compared to bisoprolol during initial titration. Any significant increases in HRV attributable to carvedilol compared to bisoprolol may emerge over a longer treatment interval in LVSD. Content Type Journal ArticleDOI 10.1007/s10557-007-6055-xAuthors Ali Hamaad, University Department of Medicine City Hospital, Dudley Road Birmingham B18 7QH UKGregory Y. H. Lip, University Department of Medicine City Hospital, Dudley Road Birmingham B18 7QH UKDeborah Nicholls, University Department of Medicine City Hospital, Dudley Road Birmingham B18 7QH UKRobert J. MacFadyen, University...

[The importance of bisoprolol in prevention of heart left ventricular hypertrophy in patients with long term L-thyroxin suppressive therapy, after the operation of differentiated thyroid carcinoma]

Endokrynologia Polska — Sat, 01 Sep 2007 04:00:00 +0100

CONCLUSIONS: 1. In differentiated thyroid cancer patients, treated postoperatively with L-thyroxine suppressive therapy, left ventricular hypertrophy is observed already during the first year of suppressive therapy and progresses during the next year of treatment. 2 Addition of a beta-adrenergic antagonist to suppressive doses of L-thyroxine causes a regression of left ventricular hypertrophy, thus, beta-adrenergic antagonists should be administered in this group of patients. PMID: 18058733 [PubMed - indexed for MEDLINE] (Source: Endokrynologia Polska)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Bisoprolol: Acute generalised exanthematous pustulosis (first report) in an elderly patient: case report

Reactions — Sun, 26 Aug 2007 12:31:32 +0100

(Source: Reactions)

Bisoprolol: Acute generalised exanthematous pustulosis (first report) in an elderly patient: case report.

Reactions Weekly — Sat, 25 Aug 2007 01:49:15 +0100

Page: 7 (Source: Reactions Weekly)

Switching beta-blocker therapy in chronic heart failure.

International Journal of Cardiology — Wed, 15 Aug 2007 04:00:00 +0100

CONCLUSION: The switch from non-recommended short-acting beta-blockers to long-acting beta-blockers may be carried out safely in stable heart failure patients. The significant reduction of the heart rate indicated that a more effective adrenergic blockage might be obtained with the switch, although physicians could titrate up to the target dose only in about one-third of the cases. PMID: 17707095 [PubMed - as supplied by publisher] (Source: International Journal of Cardiology)

Effect of selective and non-selective β -blockers on body weight, insulin resistance and leptin concentration in chronic heart failure

Clinical Research in Cardiology — Mon, 13 Aug 2007 19:47:39 +0100

Conclusion This study found different metabolic effects of carvedilol and bisoprolol in non-cachectic patients with CHF. With unchanged fasting plasma glucose concentration after 6 months of treatment, carvedilol significantly decreased plasma insulin concentration and insulin resistance compared to bisoprolol. Content TypeJournal Article JournalClinical Research in CardiologyOnline ISSN 1861-0692Print ISSN 1861-0684 (Source: Clinical Research in Cardiology)

Bisoprolol Fumarate(Bisoprolol Fumarate) Tablet, Film Coated [Aurobindo Pharma USA, Inc.]

DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) — Fri, 06 Jul 2007 05:00:00 +0100

Updated Date: Jul 6, 2007 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Adrenergic Receptor Genotype but Not Perioperative Bisoprolol Therapy May Determine Cardiovascular Outcome in At-risk Patients Undergoing Surgery with Spinal Block: The Swiss Beta Blocker in Spinal Anesthesia (BBSA) Study: A Double-blinded, Placebo-controlled, Multicenter Trial with 1-Year Follow-up.

Anesthesiology — Fri, 22 Jun 2007 02:06:45 +0100

In a double-blinded, placebo-controlled trial, β1-adrenergic receptor genotype Arg389Gly but not perioperative bisoprolol therapy determined 1-yr cardiovascular outcome in patients at risk for cardiovascular complications undergoing surgery with spinal block.Page: 33DOI: 10.1097/01.anes.0000267530.62344.a4Authors: Zaugg, Michael M.D. *; Bestmann, Lukas Ph.D. +; Wacker, Johannes M.D. ++; Lucchinetti, Eliana Ph.D. [S]; Boltres, Anita M.D. [//]; Schulz, Christian M.D. [//]; Hersberger, Martin Ph.D. #; Kalin, Gabriela B.Sc. **; Furrer, Lukas M.D. ++; Hofer, Christoph M.D. ++++; Blumenthal, Stephan M.D. [S][S]; Muller, Annabelle Ph.D. [//][//]; Zollinger, Andreas M.D. ##; Spahn, Donat R. M.D. ***; Borgeat, Alain M.D. +++ (Source: Anesthesiology)

Lung function with carvedilol and bisoprolol in chronic heart failure: Is beta selectivity relevant?

European Journal of Heart Failure — Sun, 17 Jun 2007 13:30:18 +0100

CONCLUSION: Carvedilol and bisoprolol have different effects on DLco and response to salbutamol. DLco differences, being DM related, are due to changes in active membrane transport which is under alveolar beta(2)-receptor control. Peak VO(2) was slightly higher with bisoprolol particularly in CHF patients with reduced DLco. PMID: 17561440 [PubMed - as supplied by publisher] (Source: European Journal of Heart Failure)

Which betablockers are best for the folllowing indications- heart failure - post mi prevention- angina - hypertension( in young patients)?

NLH Question Answering Service — Tue, 12 Jun 2007 18:18:44 +0100

In order to make this question more manageable to answer, we have restricted our search to secondary publications identified through the NLH Specialist Library for Cardiovascular Diseases and the CKS (formerly PRODIGY) guidelines. Heart FailureThe CKS guideline on heart failure makes the following recommendation concerning the choice of beta blockers:"Bisoprolol and carvedilol are both licensed and recommended for the treatment of heart failure. (Source: NLH Question Answering Service)

Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure

Clinical and Experimental Pharmacology and Physiology — Thu, 26 Apr 2007 10:40:55 +0100

Clinical and Experimental Pharmacology and Physiology Volume 0, Issue 0, Page ???-???. (Source: Clinical and Experimental Pharmacology and Physiology)

Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure.

European Journal of Heart Failure — Sun, 01 Apr 2007 04:00:00 +0100

CONCLUSION: Manipulation of pharmacological therapy for patients with CHF and RD results in a substantial recovery of renal function in a minority of patients. PMID: 17174600 [PubMed - in process] (Source: European Journal of Heart Failure)

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Carvedilol, a nonselective beta-blocker, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro.

Translational Research — Sun, 01 Apr 2007 04:00:00 +0100

In this study, this possibility is examined using isolated human monocytes stimulated with lipopolysaccharide (LPS) in vitro. Carvedilol (10 muM) significantly inhibited LPS-induced production of TNF and TF by monocytes, whereas prazosin (a selective alpha(1)-adrenoceptor antagonist), bisoprolol (a selective beta(1)-adrenoceptor antagonist), ICI-118,551 (a selective beta(2)-adrenoceptor antagonist), and arotinolol (a nonselective beta-adrenoceptor antagonist with alpha(1)-adrenoceptor blockade action) did not. Carvedilol inhibited both expression of early growth response factor-1 (Egr-1) and phosphorylation of extracellular signal-regulated kinase (ERK) 1/2, but it did not inhibit activation of either nuclear factor-kappaB or activator protein-1 in monocytes stimulated with LPS. These resu...

Simultaneous spectrophotometric estimation of hydrochlorothiazide and bisoprolol fumarate in combined dosage forms

Indian Journal of Pharmaceutical Sciences — Tue, 20 Mar 2007 08:20:02 +0100

Sahu R, Patel Vandana BIndian Journal of Pharmaceutical Sciences 2006 68(6):764-767Rapid, precise, accurate, and specific ratiospectra derivative spectrophotometry and a simple UV spectrophotometry using simultaneous equation methods are developed for the simultaneous determination of bisoprolol fumarate and hydrochlorothiazide from combined pharmaceutical dosage forms. For ratiospectra derivative spectrophotometry, the amplitudes were measured at 202.6 nm for bisoprolol fumarate and the difference in amplitudes at 212.6 and 230 nm were measured for the determination of hydrochlorothiazide. In the simultaneous equation method, the signals were measured at 223 nm and 271.6 nm. Concentration of each drug was obtained by using the absorptivity values calculated for the drugs at two wavelength...

Predictors of Antihypertensive Drug Responses: Initial Data from a Placebo-Controlled, Randomized, Cross-Over Study With Four Antihypertensive Drugs (The GENRES Study).

American Journal of Hypertension — Thu, 01 Mar 2007 05:00:00 +0100

CONCLUSIONS: Baseline clinical and BP parameters may be used to predict the efficacy of antihypertensive therapies. The GENRES Study material should provide an excellent platform for future pharmacogenetic analyses of antihypertensive drug responsiveness. PMID: 17324745 [PubMed - in process] (Source: American Journal of Hypertension)

Simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form by RP-HPLC method

Indian Journal of Pharmaceutical Sciences — Wed, 03 Jan 2007 06:18:02 +0100

Patel LJ, Suhagia BN, Shah PB, Shah RRIndian Journal of Pharmaceutical Sciences 2006 68(5):635-638A simple, specific, accurate and precise reverse phase high performance liquid chromatographic method was developed for the simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet dosage form. A lichrospher 100 C-18, 5 µm column 20 cm x 4.6 mm in isocratic mode, with mobile phase containing water, acetonitrile and tetrahydrofuran in proportion of 80:20:5 v/v/v were used. The flow rate was 1 ml/min, and effluent was monitored at 225 nm. The retention time of bisoprolol fumarate and hydrochlorothiazide were 1.48 ± 0.02 and 4.72 ± 0.03 min respectively, and the resolution factor was 9.0. Linearity values for bisoprolol fumarate and hydrochlorothiazide...

Real-time optical recording of {beta}1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

Journal of Clinical Investigation — Tue, 02 Jan 2007 07:00:00 +0100

Antagonists of ßbeta;-adrenergic receptors (ßbeta;-ARs) have become a main therapeutic regimen for the treatment of heart failure even though the mechanisms of their beneficial effects are still poorly understood. Here, we used fluorescent resonance energy transfer–based (FRET-based) approaches to directly monitor activation of the ßbeta;1-AR and downstream signaling. While the commonly used ßbeta;-AR antagonists metoprolol, bisoprolol, and carvedilol displayed varying degrees of inverse agonism on the Gly389 variant of the receptor (i.e., actively switching off the ßbeta;1-AR), surprisingly, only carvedilol showed very specific and marked inverse agonist effects on the more frequent Arg389 variant. These specific effects of carvedilol on the Arg389 variant o...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

Beneficial effect of combination therapy with antihypertensive drugs in patients with hypertension.

Experimental and Clinical Cardiology — Mon, 01 Jan 2007 05:00:00 +0100

CONCLUSIONS: These results indicate that combination therapy with antihypertensive drugs is usually necessary to reduce blood pressure to below 130/85 mmHg and to improve serum BNP levels. PMID: 18650977 [PubMed - in process] (Source: Experimental and Clinical Cardiology)

Changes in heart failure medications in patients hospitalised and discharged

BMC Family Practice — Thu, 23 Nov 2006 07:00:00 +0100

Conclusions: Patients suffering from HF were more likely to receive beneficial medication in hospital than prior to admission. The treatment regime then remained stable two weeks after discharge. We suggest that findings on drug continuation in different cardiovascular patients might be considered validated for patients with HF. (Source: BMC Family Practice)

Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood

Clinical Chemistry and Laboratory Medicine — Tue, 10 Oct 2006 14:53:01 +0100

Clinical Chemistry and Laboratory Medicine 44(10): 1269-1277 Background: The Roche CARDIAC proBNP point-of-care (POC) test is the first test intended for the quantitative determination of N-terminal pro-brain natriuretic peptide (NT-proBNP) in whole blood as an aid in the diagnosis of suspected congestive heart failure, in the monitoring of patients with compensated left-ventricular dysfunction and in the risk stratification of patients with acute coronary syndromes. Methods: A multicentre evaluation was carried out to assess the analytical performance of the POC NT-proBNP test at seven different sites. Results: The majority of all coefficients of variation (CVs) obtained for within-series imprecision using native blood samples was below 10% for both 52 samples measured ten times and for 6...

A Pharmacokinetic Comparison of Generic Tablets Containing Bisoprolol With the Innovator Formulation in Healthy Volunteers

The Journal of Clinical Pharmacology — Wed, 20 Sep 2006 06:00:00 +0100

(Source: The Journal of Clinical Pharmacology)

The efficacy of cibenzoline for reducing the left ventricular pressure gradient of hypertrophic obstructive cardiomyopathy: A case report

Journal of Medical Ultrasonics — Wed, 16 Aug 2006 06:20:16 +0100

Abstract A 46 year-old man with hypertrophic obstructive cardiomyopathy (HOCM) was referred to this clinic complaining of shortness of breath. His symptoms remained even after he had been treated with bisoprolol, lisinopril, and verapamil. We started treating him with cibenzoline, instead of verapamil. Continuous-wave Doppler examination revealed a marked decrease from 95.9 mm Hg to 8.8 mmHg in the left ventricular outflow tract pressure gradient after administration of cibenzoline, and the symptom disappeared. The electrical axis of the electrocardiogram deviated from +53 to +95 degrees, and the QRS interval was increased from 0.095 to 0.114 seconds. By the M-mode echocardiogram, the interventricular septum was observed moved paradoxically in the early, systolic phase. We suggest...

MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

CHARITY: Chagas cardiomyopathy bisoprolol intervention study. A randomized double-blind placebo force-titration controlled study with Bisoprolol in patients with Chronic Heart Failure secondary to Chagas Cardiomyopathy [NCT00323973]

BioMed Central — Fri, 09 Jun 2006 06:00:00 +0100

This study will allow us to explore the effect of beta-blockers in this special type of cardiomyopathy. (Source: BioMed Central)

Mylan Announces Final Approval for Bisoprolol Fumarate Tablets, USP

Drug Newswire — Sat, 20 May 2006 06:00:00 +0100

PITTSBURGH - Mylan Laboratories Inc. (NYSE:MYL) today announced that Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Bisoprolol Fumarate Tablets USP, 5mg and 10mg. Bisoprolol Fumarate Tablets, which are the AB-rated generic version of Duramed... (Source: Drug Newswire)

Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients.

Asian Journal of Andrology — Tue, 14 Mar 2006 07:00:00 +0100

CONCLUSION: Nebivolol seems to have a beneficial effect on ED (possibly due to increased nitric oxide availability); however, further prospective, randomized, placebo-controlled studies are needed to confirm the beneficial effects of nebivolol. PMID: 16491268 [PubMed - indexed for MEDLINE] (Source: Asian Journal of Andrology)

Emerging trends in the management of heart failure: Beta blocker therapy.

The Nursing Clinics of North America — Mon, 14 Mar 2005 07:00:00 +0100

Authors: Sauls JL, Rone T There is overwhelming evidence that beta blocker therapy in the form of metoprolol, bisoprolol, and carvedilol can have positive outcomes on morbidity, mortality, and quality of life in patients who have been diagnosed with mild to severe heart failure. Barring contraindications, beta blockers should be considered a cornerstone of therapy for these patients along with ACE inhibitors and diuretics. Beta blocking drugs are effective in modifying the cascade of events that occur as a result of the neurohormonal response that leads to the devastating effects evident during heart failure. Long-term effects of beta blockade include an increase in cardiac output, an increase in exercise tolerance, a decrease in the number of hospitalizations, and an overall improveme...